PeerVoice Immunology & Infectious Disease Audio: Recent Episodes
PeerVoice
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context
Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG
James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
Enrico Lopriore, MD, PhD - Are You Managing Pregnant Individuals? Then You Need to Know About Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT)
Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis
Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data
Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow
Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care
Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey
Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?
Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?
Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA
Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making
Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care
Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?
Frank Siebenhaar, MD - Indolent Isn’t Insignificant: Raising Awareness of Systemic Mastocytosis and Its Symptoms
Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?
Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?
Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?
Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology
Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know
Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents
Andrew Ustianowski, MBBS, FRCP, PhD - What’s Right for Me: Individualising Antiretroviral Therapy in People Living With HIV
Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?
Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment?
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections
Shimu Khamlichi, BSc, ClinPsyD - Protecting the Mental Health of People Living With HIV
Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts
Luke Stephen Prockter Moore, FRCP, FRCPath, PhD - A Cohesive Multidisciplinary Approach to Antimicrobial Stewardship: Joining the Dots on Rapid Diagnostic Testing
Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression
José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
Help, I Have COVID': Primary Care Support and Therapeutic Management of Patients With Mild/Moderate COVID-19
JAK Inhibitors in the Management of Dermatologic Disorders: Clinical Implications of the Latest Safety Findings
"Anil K. Gupta, MD, CCFP, FCFP - Preventing COVID Progression and Transmission in the Outpatient Setting: Keeping Abreast of Therapeutic Developments"
"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"
Simplifying Screening for Immunodeficiencies: A Practical Strategy Using Calculated Serum Globulin
Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis
Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
Weighing Evidence and Perspectives on JAK Inhibitors in Psoriatic Arthritis: Can We Do More for Patients?
"Case Studies in Locally Advanced and Metastatic CSCC: Integrating Immunotherapy Into Current Treatment Paradigms"
Wake Up and Smell the Coffee: Kicking Into Play Novel Treatment Options for Nasal Polyposis
Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control
Wheeze, Asthma, and Lung Function: Latest Insights on the Long-Term Impact of Severe RSV in Infancy
Management of Autoinflammatory Recurrent Fever Syndromes: What Recent Data Results Mean for Clinical Practice
Treatment Initiation and Persistence in HIV: The Case for Optimisation in the Real World
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
Conversations on Steps to Biologic Therapy for Atopic Dermatitis: Patient and Dermatologist Insights for European Practice
Protecting Adolescents and Adults From Vaccine Preventable Bacterial Diseases: A Look at Serogroup B Meningococcal Disease and Pneumococcal Diseases
Treating Rheumatoid Arthritis and Spondyloarthritis to Target: What Are We Missing in Clinical Practice?
Von der Krankheitsentstehung zu klinischen Strategien für autoinflammatorische und Autoimmunerkrankungen: Welche Rolle spielen Interleukine?
Enthesitis in Psoriatic Arthritis and Spondyloarthritis: Targeting Pathophysiologic Mechanisms to Optimise Patient Management
Defining the Optimal Respiratory Syncytial Virus Infection Management Strategy: Applying Health Economics to Improve Patient Outcomes